McMurray JJV - Search Results

1

Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial.

Singh AK, Cizman B, Carroll K, McMurray JJV, Perkovic V, Jha V, Johansen KL, Lopes RD, Macdougall IC, Obrador GT, Waikar SS, Wanner C, Wheeler DC, Wiecek A, Stankus N, Strutz F, Blackorby A, Cobitz AR, Meadowcroft AM, Paul G, Ranganathan P, Sedani S, Solomon S. Singh AK, et al. Among authors: mcmurray jjv. JAMA Intern Med. 2022 Jun 1;182(6):592-602. doi: 10.1001/jamainternmed.2022.0605. JAMA Intern Med. 2022. PMID: 35377393 Free PMC article. Clinical Trial.

2

Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial.

Sampson UK, Pfeffer MA, McMurray JJ, Lokhnygina Y, White HD, Solomon SD; VALIANT Trial Investigators. Sampson UK, et al. Eur Heart J. 2007 Mar;28(6):685-91. doi: 10.1093/eurheartj/ehl197. Epub 2006 Sep 19. Eur Heart J. 2007. PMID: 16984929 Clinical Trial.

3

Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.

Stephenson K, Skali H, McMurray JJ, Velazquez EJ, Aylward PG, Kober L, Van de Werf F, White HD, Pieper KS, Califf RM, Solomon SD, Pfeffer MA. Stephenson K, et al. Heart Rhythm. 2007 Mar;4(3):308-13. doi: 10.1016/j.hrthm.2006.11.021. Epub 2006 Nov 29. Heart Rhythm. 2007. PMID: 17341394 Clinical Trial.

4

The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study.

Verma A, Anavekar NS, Meris A, Thune JJ, Arnold JM, Ghali JK, Velazquez EJ, McMurray JJ, Pfeffer MA, Solomon SD. Verma A, et al. J Am Coll Cardiol. 2007 Sep 25;50(13):1238-45. doi: 10.1016/j.jacc.2007.06.018. Epub 2007 Sep 10. J Am Coll Cardiol. 2007. PMID: 17888840 Free article. Clinical Trial.

5

Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program.

Desai AS, Swedberg K, McMurray JJ, Granger CB, Yusuf S, Young JB, Dunlap ME, Solomon SD, Hainer JW, Olofsson B, Michelson EL, Pfeffer MA; CHARM Program Investigators. Desai AS, et al. J Am Coll Cardiol. 2007 Nov 13;50(20):1959-66. doi: 10.1016/j.jacc.2007.07.067. Epub 2007 Oct 29. J Am Coll Cardiol. 2007. PMID: 17996561 Free article.

6

Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.

Thomas KL, Al-Khatib SM, Lokhnygina Y, Solomon SD, Kober L, McMurray JJ, Califf RM, Velazquez EJ. Thomas KL, et al. Am Heart J. 2008 Jan;155(1):87-93. doi: 10.1016/j.ahj.2007.09.010. Epub 2007 Oct 25. Am Heart J. 2008. PMID: 18082495 Clinical Trial.

7

Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.

Weir RA, McMurray JJ, Puu M, Solomon SD, Olofsson B, Granger CB, Yusuf S, Michelson EL, Swedberg K, Pfeffer MA; CHARM Investigators. Weir RA, et al. Eur J Heart Fail. 2008 Feb;10(2):157-63. doi: 10.1016/j.ejheart.2007.12.006. Epub 2008 Jan 31. Eur J Heart Fail. 2008. PMID: 18242128 Free article. Clinical Trial.

8

High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.

Anderson RE, Pfeffer MA, Thune JJ, McMurray JJ, Califf RM, Velazquez E, White HD, Rouleau JL, Skali H, Maggioni A, Solomon SD. Anderson RE, et al. Am Heart J. 2008 Apr;155(4):706-11. doi: 10.1016/j.ahj.2007.11.016. Epub 2008 Jan 31. Am Heart J. 2008. PMID: 18371480 Clinical Trial.

9

Approaches to the treatment of anaemia in patients with chronic heart failure.

Murphy CL, McMurray JJ. Murphy CL, et al. Heart Fail Rev. 2008 Dec;13(4):431-8. doi: 10.1007/s10741-008-9085-y. Epub 2008 Apr 8. Heart Fail Rev. 2008. PMID: 18392791 Free article. Review.

10

Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT).

Berry C, Pieper KS, White HD, Solomon SD, Van de Werf F, Velazquez EJ, Maggioni AP, Califf RM, Pfeffer MA, McMurray JJ. Berry C, et al. Eur Heart J. 2009 Jun;30(12):1450-6. doi: 10.1093/eurheartj/ehp102. Epub 2009 Apr 3. Eur Heart J. 2009. PMID: 19346225 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,157 results

Search Page